Reaction

Clumsiness reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,712 reports · 100 co-occurring drugs

As of the last recalculation, Clumsiness appears in 2,712 FAERS reports alongside 100 co-occurring drug terms. The strongest observed disproportionality signal is DIROXIMEL FUMARATE (PRR 18.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Diroximel Fumarate	28	18.2	18.3
Rabeprazole	40	14.0	14.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled	32	11.6	11.6
Cenobamate	12	11.1	11.1
Felodipine Extended-Release Tablets	16	10.8	10.9
Felodipine	16	10.8	10.9
Primidone	13	9.8	9.8
Fingolimod Hcl	106	9.7	9.8
Liothyronine Sodium	11	9.7	9.7
Dalfampridine	85	9.4	9.4
Fesoterodine Fumarate	13	9.2	9.3
Ocrelizumab	71	9.0	9.0
Modafinil	37	8.9	8.9
Clobazam	28	8.9	8.9
Lamotrigine	131	8.0	8.0
Butalbital, Acetaminophen, And Caffeine	11	7.9	8.0
Amitriptyline Hydrochloride	18	7.9	7.9
Lithium Carbonate	17	7.7	7.7
Ofatumumab	33	7.7	7.7
Ketoprofen	13	7.6	7.6
Rizatriptan Benzoate	10	7.6	7.6
Bisacodyl Suppositories	12	7.1	7.2
Biscodyl	12	7.1	7.1
Phenytoin	19	7.0	7.0
Lamotirigine	64	7.0	7.0
Lamotrigine Extended-Release	64	7.0	7.0
Lamotrigine Chewable Dispersible	64	7.0	7.0
Indomethacin	12	7.0	7.0
Asfotase Alfa	9	6.9	6.9
Phenobarbital	13	6.9	6.9
Lacosamide	33	6.9	6.9
Topiramate	81	6.8	6.8
Natalizumab	152	6.7	6.7
Valproate Sodium	18	6.7	6.7
Diazepam Oral Solution (Concentrate)	75	6.6	6.6
Diazepam Oral	75	6.6	6.6
Rosuvastatin Calcium	24	6.6	6.6
Bisacodyl	12	6.6	6.6
Carbamazepine	56	6.5	6.5
Telmisartan	15	6.5	6.5
Amantadine	13	6.5	6.5
Paroxetine Hydrochloride	71	6.1	6.1
Clonazepam	121	6.0	6.0
Teriflunomide	35	6.0	6.0
Oxcarbazepine	24	5.7	5.7
Diazepam	88	5.7	5.7
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	26	5.7	5.7
Ritonavir 100 Mg	11	5.7	5.7
Baclofen	62	5.6	5.6
Extended Phenytoin Sodium	12	5.5	5.5
Dimethyl Fumarate	82	5.2	5.2
Methylphenidate Hydrochloride	40	5.2	5.2
Lisdexamfetamine Dimesylate	22	5.1	5.2
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	27	5.0	5.0
Vilazodone Hydrochloride	6	5.0	5.0
Pregabalin	168	5.0	5.0
Biotin	20	4.9	5.0
Raloxifene Hydrochloride	9	4.7	4.7
Zonisamide	9	4.7	4.7
Oxazepam	13	4.7	4.7
Estradiol Gel 0.1%	27	4.6	4.6
Estradiol Transdermal	27	4.6	4.6
Sodium Oxybate	38	4.5	4.5
Siponimod	5	4.3	4.3
Desvenlafaxine Succinate	15	4.3	4.3
Brivaracetam	5	4.3	4.3
Levetiracetam	70	4.1	4.1
Interferon Beta-1A	99	4.0	4.0
Interferon Beta-1B	10	4.0	4.0
Ethyl Alcohol	14	4.0	4.0
Vigabatrin	7	3.7	3.7
Calcium, Magnesium, Potassium, And Sodium Oxybates	4	3.6	3.6
Peginterferon Beta-1A	6	3.5	3.5
Isopropyl Alcohol	15	3.4	3.4
Dolutegravir Sodium	4	3.4	3.4
Nevirapine	4	3.4	3.4
Fremanezumab-Vfrm	5	3.3	3.3
Armodafinil	9	3.3	3.3
Methylphenidate	12	3.2	3.2
Rotigotine	6	3.2	3.2
Glatiramer Acetate	22	2.8	2.8
Alcohol	14	2.8	2.8
Ozanimod Hydrochloride	3	2.8	2.8
Buprenorphine	32	2.7	2.7
Naltrexone	10	2.5	2.5
Elexacaftor, Tezacaftor, And Ivacaftor	4	2.5	2.5
Drospirenone And Ethinyl Estradiol	14	2.4	2.4
Rimegepant Sulfate	4	2.4	2.4
Pseudoephedrine Hydrochloride	3	2.2	2.2
Paliperidone Palmitate	9	2.2	2.2
Pseudoephedrine Hcl	3	2.1	2.1
Cannabidiol	6	2.0	2.0
Ixazomib	7	1.9	1.9
Erenumab-Aooe	12	1.7	1.7
Valbenazine	5	1.5	1.5
Droxidopa	4	1.4	1.4
Pomalidomide	19	1.4	1.4
Esketamine Hydrochloride	3	1.3	1.3
Galcanezumab-Gnlm	5	1.2	1.2
Pimavanserin Tartrate	8	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.